REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMAâ„¢ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program…